Eliquis 5 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DR26FGJS5
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $4,548
Award facts
- Contract value 100% obligated
- $4,548.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $4,548.20 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for 60 tablets of Eliquis 5 mg. The contract is a firm fixed-price delivery order with an ultimate completion date of November 18, 2025, and was issued without a set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency, specifically the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative.
DMS Pharmaceutical Group holds a single-award IDC under the PPV-G GEN V program, which was awarded on November 13, 2025, with a ceiling value of $499.999 billion and an ultimate completion date of December 31, 2036. The PPV-G GEN V represents a component of the broader $30.3 billion Defense Logistics Agency pharmaceutical acquisition strategy designed to supply Department of Defense military healthcare facilities worldwide with comprehensive pharmaceutical products, including branded and generic prescription drugs, biologics, and medical consumables. As a critical regional prime vendor contractor, DMS Pharmaceutical Group is positioned to fulfill diverse specialized pharmaceutical requirements across the federal military medical system through firm fixed-price delivery orders.
Quick answers
Who was awarded contract SPE2DR26FGJS5?
SPE2DR26FGJS5 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 17, 2025.
How much is contract SPE2DR26FGJS5 worth?
The government has obligated $4,548 on SPE2DR26FGJS5.
Is contract SPE2DR26FGJS5 an order under another contract?
Yes. SPE2DR26FGJS5 is a delivery order under SPE2DR25D9832, an indefinite delivery contract.
Was contract SPE2DR26FGJS5 competed?
The extent of competition for SPE2DR26FGJS5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award